Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket News PRO 3 hours ago Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.Read More Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Share on Reddit (Opens in new window) Reddit Share on LinkedIn (Opens in new window) LinkedIn Share on Pinterest (Opens in new window) Pinterest Share on Tumblr (Opens in new window) Tumblr Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soarDateAugust 7, 2025In relation toFinancial NewsEli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soarDateFebruary 4, 2026In relation toFinancial NewsEli Lilly launches platform for AI-enabled drug discoveryDateSeptember 9, 2025In relation toTech News
